LogicBio Therapeutics Inc.

NAS: LOGC

GO
/marketstate/country/us

Market open

 --Real time quotes

Mar 5, 2021, 9:30 a.m.

/zigman2/quotes/206745651/composite

$

7.75

Change

-0.09 -1.15%

Volume

Volume 13,032

Real time quotes

/zigman2/quotes/206745651/composite

Previous close

$ 7.84

$ 7.75

Change

-0.09 -1.15%

Day low

Day high

$7.74

$7.75

Open

52 week low

52 week high

$3.05

$10.00

Open

Company Description

LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded ...

LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Cambridge, MA.

Valuation

Price to Book Ratio

3.92

Total Debt to Enterprise Value

0.08

Efficiency

Income Per Employee

-978,732.00

Liquidity

Current Ratio

14.83

Quick Ratio

14.83

Cash Ratio

14.26

Profitability

Return on Assets

-57.92

Return on Equity

-65.51

Return on Total Capital

-61.80

Return on Invested Capital

-60.65

Capital Structure

Total Debt to Total Equity

24.39

Total Debt to Total Capital

19.61

Total Debt to Total Assets

18.53

Long-Term Debt to Equity

23.20

Long-Term Debt to Total Capital

18.65

Officers and Executives

Name Age Officer Since Title
Dr. Richard A. Moscicki 67 2018 Independent Director
Mr. Frédéric Chéreau 53 2016 President, Chief Executive Officer & Director
Dr. Kyle Chiang 40 2016 Chief Operating Officer
Mr. Jonathan Quick - 2019 Senior Finance Director
Ms. Cecilia Jones 45 2021 Chief Financial Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/01/2021 Mark A. Kay
Director
2,199   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Leon E. Chen
Director
3,298   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Richard A. Moscicki
Director
3,916   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Michael S. Wyzga
Director
3,141   Derivative/Non-derivative trans. at $0 per share. 0
01/01/2021 Mark J. Enyedy
Director
2,921   Derivative/Non-derivative trans. at $0 per share. 0
12/10/2020 Daniel O’Connell
Director
2,513   Derivative/Non-derivative trans. at $0 per share. 0
09/25/2020 Arix Bioscience Plc
174,219   Disposition at $7.08 per share. 1,233,470
09/24/2020 Arix Bioscience Plc
38,514   Disposition at $7.63 per share. 293,861
08/13/2020 Arix Bioscience Plc
159   Disposition at $8.75 per share. 1,391
08/12/2020 Arix Bioscience Plc
1,335   Disposition at $8.79 per share. 11,734
07/29/2020 Arix Bioscience Plc
2,709   Disposition at $8.78 per share. 23,785
07/22/2020 Arix Bioscience Plc
22,651   Disposition at $9 per share. 203,859
07/20/2020 Arix Bioscience Plc
36,983   Disposition at $9.25 per share. 342,092
07/17/2020 Arix Bioscience Plc
31,101   Disposition at $9.24 per share. 287,373
/news/latest/company/us/logc

MarketWatch News on LOGC

No News currently available for LOGC

/news/nonmarketwatch/company/us/logc

Other News on LOGC

  1. LogicBio Therapeutics names new CFO

    12:45 p.m. Dec. 22, 2020

    - Seeking Alpha

  2. Looking In On LogicBio

    12:04 a.m. Nov. 17, 2020

    - Seeking Alpha

  3. 10-Q: LOGICBIO THERAPEUTICS, INC.

    8:23 a.m. Nov. 9, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. LogicBio Therapeutics announces executive leadership changes

    4:40 p.m. Nov. 3, 2020

    - Seeking Alpha

  5. BBBY, AMAG, GNFT and ZSAN among midday movers

    11:39 a.m. Oct. 1, 2020

    - Seeking Alpha

  6. LogicBio therapeutics -30% on pricing of equity offering

    8:18 a.m. Oct. 1, 2020

    - Seeking Alpha

  7. GNW, SELB among premarket losers

    7:16 a.m. Oct. 1, 2020

    - Seeking Alpha

  8. LogicBio Therapeutics (LOGC) Jumps: Stock Rises 6.1%

    10:21 a.m. Sept. 29, 2020

    - Zacks.com

  9. EXAS, OMI, GLNG and DGLY among midday movers

    11:43 a.m. Sept. 24, 2020

    - Seeking Alpha

  10. BB, CODX among premarket gainers

    7:28 a.m. Sept. 24, 2020

    - Seeking Alpha

  11. 10-Q: LOGICBIO THERAPEUTICS, INC.

    7:16 a.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  12. 10-Q: LOGICBIO THERAPEUTICS, INC.

    4:06 p.m. May 11, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  13. Loading more headlines...

At a Glance

LogicBio Therapeutics, Inc.

65 Hayden Avenue

Lexington, Massachusetts 02421

Phone

1 6172450399

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

N/A

Net Income

$-40.13M

Employees

41.00

/news/pressrelease/company/us/logc

Press Releases on LOGC

  1. LogicBio Therapeutics to Present at Upcoming Investor Conferences

    2:15 p.m. Feb. 26, 2021

    - PR Newswire - PRF

  2. Loading more headlines...
Link to MarketWatch's Slice.